Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor.

Dilly, Sébastien; Romero, Miguel; Solier, Stéphanie; Feron, Olivier; Dessy, Chantal; Slama Schwok, Anny.

Afiliação

Dilly S; Gustave Roussy Cancer Center, CNRS UMR 8200, F-94805 Villejuif, France.
Romero M; Pole of Pharmacology and Therapeutics (FATH), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain, B-1200 Brussels, Belgium.
Solier S; Department of Pharmacology, School of Pharmacy, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain.
Feron O; Gustave Roussy Cancer Center, INSERM U1170, F-94805 Villejuif, France.
Dessy C; Pole of Pharmacology and Therapeutics (FATH), Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain, B-1200 Brussels, Belgium.
Slama Schwok A; WELBIO Department, WEL Research Institute, Avenue Pasteur, 6, B-1300 Wavre, Belgium.

Antioxidants (Basel) ; 12(2)2023 Feb 10.

Article em En | MEDLINE | ID: mdl-36830003